Menu
Stock Lookup
Search by symbol or company name, then inspect the chart and stock properties.
US
RLMD Relmada Therapeutics, Inc.
TradingView
As Of 8/12/26
Analyst Data
Refresh analyst earnings estimates and rating summary for this symbol only.
Close
4.7300
Day %
7.01%
RS
N/A
Ind Rank
#51
RS 1D
N/A
RS 1W
93
RS 1M
95
RS 3M
98
RS 6M
N/A
Consensus Rating
Buy
Current Quarter EPS
-0.18
Next Quarter EPS
-0.19
Current Year EPS
-0.72
Next Year EPS
-1.18
ExchangeUS
Market Cap0 B
52W High8.0000
From 52W High-40.88%
Open4.5300
High4.8100
Low4.5100
OptionsNo
ActiveYes
RS TypeFull
RS Date2026-08-11
Bars Available310
Scanner Hits6
Last Scanner Hit2026-06-30
Recent Scanner History
6 matching / 6 total| Date | Scanner | RS |
|---|---|---|
| 2026-06-30 |
Extreme Contraction
US_EXTREME_CONTRACTION
|
94 |
| 2026-06-22 |
Extreme Contraction
US_EXTREME_CONTRACTION
|
95 |
| 2026-05-29 |
Contraction
US_CONTRACTION
|
97 |
| 2026-05-28 |
Contraction
US_CONTRACTION
|
97 |
| 2026-05-19 |
Setup Scan
US_PPC
|
98 |
| 2026-05-14 |
Contraction
US_CONTRACTION
|
98 |
Analyst Snapshot
As Of 3/29/26| Consensus | Current Quarter EPS | Next Quarter EPS | Current Year EPS | Next Year EPS |
|---|---|---|---|---|
| Buy | -0.18 | -0.19 | -0.72 | -1.18 |
Based on 4 analysts offering recommendations for 'RLMD'.
Quarterly EPS Forecasts
5 rows| Period | Consensus EPS | High | Low | Estimates | Revisions |
|---|---|---|---|---|---|
| Mar 2026 | -0.18 | -0.17 | -0.19 | 2 |
▲
0
▼
1
|
| Jun 2026 | -0.19 | -0.18 | -0.19 | 2 |
▲
0
▼
0
|
| Sep 2026 | -0.20 | -0.20 | -0.20 | 2 |
▲
1
▼
0
|
| Dec 2026 | -0.22 | -0.21 | -0.23 | 2 |
▲
1
▼
0
|
| Mar 2027 | -0.27 | -0.27 | -0.27 | 1 |
▲
0
▼
0
|
Yearly EPS Forecasts
2 rows| Period | Consensus EPS | High | Low | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | -0.72 | -0.60 | -0.79 | 3 |
▲
1
▼
0
|
| Dec 2027 | -1.18 | -1.11 | -1.24 | 2 |
▲
1
▼
0
|